Results: There were 2189 patients identified; 524 (24.9%) underwent concurrent fasciotomy, and 1665 (76.1%) underwent embolectomy alone. Patients with concurrent fasciotomy were younger (69 vs 71 years; P <.01) and more likely to be diabetic (30% vs 25%; P ¼ .02) and smokers (33% vs 26%; P < .01). Patients with concurrent fasciotomy had significantly higher 30-day mortality, unplanned return to the operating room, and renal and wound infections. These differences persisted in multivariable analysis (Table) . In addition, patients who did not have concurrent fasciotomy did not require a significantly higher rate of delayed fasciotomy (2.0% vs 0.8%; P ¼ .06) or 30-day amputation (3.1% vs 4.6%; P ¼ .11).
IP203.

Initial Improvement in Ankle-Brachial Index After Vein Bypass for Rest Pain Predicts Limb Salvage
Senthil N. Jayarajan Objective: Although revascularization for limb salvage in critical limb ischemia is accepted as standard practice, previous studies have not identified a threshold improvement in ankle-brachial index (ABI) after bypass beyond which major amputation is less likely. We sought to establish this threshold through analysis of the Edifoligide for the Prevention of Vein Graft Failure in Lower Extremity Bypass SurgerydPhase III Trial (PRE-VENT III) database.
Methods: The PREVENT III study was a randomized, multicenter trial of edifoligide for the prevention of vein graft failure. All vein bypasses for rest pain only in the study cohort were included. Patients with ABI >1.2 at preoperative and immediate postoperative testing were excluded because of concerns for incompressibility. The difference between the preoperative and 1-month follow up ABIs was defined as the delta ABI. A receiver operating characteristic curve was constructed to generate the optimal cutoff point for sensitivity and specificity (based on Youden index) for delta ABI at 1 year. The outcome measured was amputationfree survival; this was analyzed using Kaplan-Meier method and multivariate Cox regression analysis.
Results: Of the 174 patients included, 14 (7.8%) required amputation by 1 year. Whereas the amputation group (56.5 years vs. 67.4 years; P > .01) was younger, there was no difference in sex, race, preoperative dialysis status, distal bypasses, and diabetes. The amputation group had more high-risk bypasses (50% vs 24.4%; P ¼ .03) and postoperative anticoagulation (92.2% vs 44.4%; P ¼ .01). The amputation group had similar baseline ABI (amputation, mean 0.35; no amputation, mean 0.29; P ¼ .203) but lower postoperative ABI (0.74 vs 0.9; P ¼ .018) and delta ABI (0.38 vs 0.61; P ¼ 0.009; Fig 1) . The optimal threshold identified for delta ABI was 0.56 (sensitivity, 0.82; specificity, 0.63). On univariate survival analysis, amputation-free survival was 97% for delta ABI >0.56 and 84% for delta ABI <0.56 at 1 year (P ¼ .003; Fig 2) . On Cox regression analysis, delta ABI >0.56 showed an 86.7% less likelihood of amputation.
Conclusions: A threshold improvement in ABI >0.56 is associated with greater likelihood of limb salvage and appears to be more pronounced over the 1-year duration of the study. Further studies are needed to validate this threshold. Objective: Preoperative anemia is associated with increased morbidity and mortality after surgical operations. The purpose of this study was to examine the impact of preoperative anemia on outcomes among patients with peripheral arterial disease who have undergone open lower extremity bypass.
Methods: The American College of Surgeons National Surgical Quality Improvement Program database for year 2013 was used for this analysis. Patients were organized into three groups based on hemoglobin level: severe anemia (<10 g/dL), mild anemia (10-12 g/dL for women and 10-13 g/dL for men), and no anemia (>12 g/dL). Bivariable analysis was performed for preoperative, intraoperative, and postoperative risk factors among patients with anemia. Multivariable analysis was used to determine risk factors associated with mortality and limb loss.
Results: A total of 2381 patients (31.9% women, 68.1% men) were identified in the National Surgical Quality Improvement Program database who underwent lower extremity bypass in the year 2013. Among these patients, 328 (14.0%) had severe anemia, 898 (38.3%) had mild anemia, and 1120 (47.7%) did not have anemia. Patients with severe anemia were more likely to have a history of hypertension, diabetes, dialysis dependence, congestive heart failure, cancer, preoperative transfusion, and critical limb ischemia presenting as tissue loss (P < .05). They were also more likely to have a hospital stay >7 days, cardiac arrest requiring cardiopulmonary resuscitation, postoperative acute renal failure, return to the operating room, unplanned reoperation related to lower extremity bypass, and bleeding requiring transfusion (P < .05). On multivariable analysis, the following factors were found to have a significant association with mortality: dialysis (odds ratio [OR], 4.1; confidence interval [CI], 0.5-2.2; P < .05), myocardial infarction or stroke (OR, 9.4; CI, 1.3-5.3; P < .05), and length of hospital stay >7 days (OR, 1.9; CI, 1.3-5.3; P < .05). The following factors had strong association with limb loss: dialysis (OR, 1.9; CI, 1.0-3.5; P < .05), myocardial infarction or stroke (OR, 1.7; CI, 1.1-2.8; P < .05), and hospital stay >7 days (OR, 7.1; CI, 3.9-13.3; P < .05). Neither mild nor severe anemia was found to be a significant factor for death and amputation on multivariable analysis.
Conclusions: This study does not show any significant correlation between anemia and mortality or limb loss, suggesting the importance of other factors instead. Objective: Previous studies comparing endovascular revascularization (ENDO) and surgical bypasses (OPEN) for lower extremity arterial occlusive disease often do not differentiate outcomes for femoral/popliteal and infrapopliteal diseases. In this study, we investigate the 30-day outcomes/limb salvage of OPEN vs ENDO in patients with critical limb ischemia (CLI) in each disease category: superficial femoral/popliteal (SFA/POP) or infrapopliteal occlusive disease.
Methods: Patients who underwent interventions for CLI were identified in the targeted American College of Surgeons National Surgical Quality Improvement Program database from 2011 to 2015. They were first stratified by type of intervention (OPEN vs ENDO), then by indication (rest pain and tissue loss) and anatomic interventions (SFA/POP and infrapopliteal). The 30-day outcomes, especially amputation rate, were compared between ENDO and OPEN in each anatomic distribution for rest pain or tissue loss. Multivariate regression was performed for analysis.
Results: There were 10,624 patients revascularized for CLI: 3938 received ENDO and 6686 underwent OPEN. ENDO patients were more likely to have end-stage renal disease, congestive heart failure, hypertension, and diabetes. OPEN patients were more likely to smoke, to have chronic obstructive pulmonary disease, and to have American Society of Anesthesiologists score 4 or 5. There was no statistically significant difference in 30-day mortality (2.4% vs 2.7%; P ¼ .3) between OPEN and ENDO across all groups. ENDO was associated with fewer cardiac, pulmonary, and wound complications but a higher rate of major amputations (5.3% vs 4.3%; P ¼ .018) within 30 days (Table) . Patients with tissue loss had a higher rate of amputation than did those with rest pain (5.4% vs 3.6%; P < .0001). Amputation rate in patients with rest pain was not influenced by anatomic location or type of intervention. However, further analysis in Table. The 30-day outcomes of surgical bypasses (OPEN) vs endovascular interventions (ENDO) in patients with critical limb ischemia (CLI) 
